Chandrajit P. Raut, M.D., M.Sc. is an Associate Professor of Surgery at Harvard Medical School, Associate Surgeon in the Division of Surgical Oncology at Brigham and Women’s Hospital, and Surgery Director of the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute. A graduate of Stanford University (BA/BS), University of Oxford (MSc), and Harvard Medical School (MD), he completed his general surgery residency at Massachusetts General Hospital and surgical oncology fellowship at M.D. Anderson Cancer Center.
Dr. Raut specializes almost exclusively in the multidisciplinary care of patients with soft tissue sarcoma. His research focuses on clinical trials and novel therapeutics to lower locoregional recurrence rates following sarcoma resection. He is co-investigator on a phase III clinical trial evaluating the use of preoperative radiation therapy for retroperitoneal sarcomas, co-principal investigator (PI) on a phase II clinic trial evaluating 5 years of adjuvant imatinib for primary GIST, and member of the NIH/NCI The Cancer Genome Atlas Sarcoma Working Group. He has a multi-PI NIH R01 grant evaluating an innovative drug-eluting film to be placed in the surgical bed to reduce tumor local recurrence rates.
Dr. Raut is the Program Director of the Complex Surgical Oncology Fellowship at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Massachusetts General Hospital. He serves as Section Editor for sarcoma in the journals Cancer and Annals of Surgical Oncology and Associate Editor for the journal Sarcoma.
Transatlantic Australasian Retroperitoneal Sarcoma Working Group 